Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2017 May;6(5):1332-1339.
doi: 10.1002/sctm.16-0474. Epub 2017 Apr 5.

Autologous Cord Blood Infusions Are Safe and Feasible in Young Children With Autism Spectrum Disorder: Results of a Single-Center Phase I Open-Label Trial

Affiliations
Free PMC article
Clinical Trial

Autologous Cord Blood Infusions Are Safe and Feasible in Young Children With Autism Spectrum Disorder: Results of a Single-Center Phase I Open-Label Trial

Geraldine Dawson et al. Stem Cells Transl Med. .
Free PMC article

Abstract

Despite advances in early diagnosis and behavioral therapies, more effective treatments for children with autism spectrum disorder (ASD) are needed. We hypothesized that umbilical cord blood-derived cell therapies may have potential in alleviating ASD symptoms by modulating inflammatory processes in the brain. Accordingly, we conducted a phase I, open-label trial to assess the safety and feasibility of a single intravenous infusion of autologous umbilical cord blood, as well as sensitivity to change in several ASD assessment tools, to determine suitable endpoints for future trials. Twenty-five children, median age 4.6 years (range 2.26-5.97), with a confirmed diagnosis of ASD and a qualified banked autologous umbilical cord blood unit, were enrolled. Children were evaluated with a battery of behavioral and functional tests immediately prior to cord blood infusion (baseline) and 6 and 12 months later. Assessment of adverse events across the 12-month period indicated that the treatment was safe and well tolerated. Significant improvements in children's behavior were observed on parent-report measures of social communication skills and autism symptoms, clinician ratings of overall autism symptom severity and degree of improvement, standardized measures of expressive vocabulary, and objective eye-tracking measures of children's attention to social stimuli, indicating that these measures may be useful endpoints in future studies. Behavioral improvements were observed during the first 6 months after infusion and were greater in children with higher baseline nonverbal intelligence quotients. These data will serve as the basis for future studies to determine the efficacy of umbilical cord blood infusions in children with ASD. Stem Cells Translational Medicine 2017;6:1332-1339.

Keywords: Autism spectrum disorder; Autologous umbilical cord blood; Cell therapy.

Figures

Figure 1
Figure 1
Frequency of adverse events. Number of patients reporting an event is listed in parentheses.
Figure 2
Figure 2
Vineland Adaptive Behavior Scales‐II (VABS‐II) Socialization Standard Score. (A): Distribution of VABS‐II Socialization Standard Score in all participants over time. (B): Distribution of VABS‐II Socialization Score stratified by nonverbal intelligence quotient.
Figure 3
Figure 3
Global Impression Scale (GCI). (A): CGI‐Severity over time. (B): CGI‐Improvement over baseline as assessed at 6 and 12 months.

Similar articles

See all similar articles

Cited by 24 articles

See all "Cited by" articles

References

    1. Baio J. Prevalence of autism spectrum disorder among children aged 8 years—Autism and developmental disabilities monitoring network, 11 sites, United States, 2010. MMWR Surveill Summ 2014;63:1–21. - PubMed
    1. Buescher AS, Cidav Z, Knapp M et al. Costs of autism spectrum disorders in the United Kingdom and the United States. JAMA Pediatr 2014;168:721–728. - PubMed
    1. Dawson G, Rogers S, Munson J et al. Randomized, controlled trial of an intervention for toddlers with autism: The early start denver model. Pediatrics 2010;125:e17–e23. - PMC - PubMed
    1. de la Torre‐Ubieta L, Won H, Stein JL et al. Advancing the understanding of autism disease mechanisms through genetics. Nat Med 2016;22:345–361. - PMC - PubMed
    1. Mandy W, Lai MC. Annual Research Review: The role of the environment in the developmental psychopathology of autism spectrum condition. J Child Psychol Psychiatry 2016;57:271–292. - PubMed

Publication types

Feedback